AVUSX
Price
$18.15
Change
-$0.08 (-0.44%)
Updated
Sep 20 closing price
VITSX
Price
$136.99
Change
-$0.34 (-0.25%)
Updated
Sep 20 closing price
Ad is loading...

AVUSX vs VITSX

Header iconAVUSX vs VITSX Comparison
Open Charts AVUSX vs VITSXBanner chart's image
Avantis® U.S. Equity Institutional
Price$18.15
Change-$0.08 (-0.44%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Market Idx I
Price$136.99
Change-$0.34 (-0.25%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
AVUSX vs VITSX Comparison Chart
Loading...
VS
AVUSX vs. VITSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVUSX is a StrongBuy and VITSX is a Buy.

FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.72T vs. AVUSX (757M). VITSX pays higher dividends than AVUSX: VITSX (1.36) vs AVUSX (1.08). AVUSX was incepted earlier than VITSX: AVUSX (5 years) vs VITSX (27 years). AVUSX is a more actively managed with annual turnover of: 7.00 vs. VITSX (2.00). AVUSX (5000000) and VITSX (5000000) have matching initial minimum investment requirements. VITSX (31.57) and AVUSX (30.36) have marching annual gain over last year.
AVUSXVITSXAVUSX / VITSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years27 years-
Gain YTD17.00918.65191%
Front LoadN/AN/A-
Min. Initial Investment50000005000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets757M1.72T0%
Annual Yield % from dividends1.081.3679%
Returns for 1 year30.3631.5796%
Returns for 3 years31.4925.36124%
Returns for 5 yearsN/A85.68-
Returns for 10 yearsN/A188.34-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIPC42.450.13
+0.31%
Brookfield Infrastructure Corp
A140.09-1.86
-1.31%
Agilent Technologies
PHAT18.43-0.29
-1.55%
Phathom Pharmaceuticals
WTBA19.68-0.34
-1.70%
West Bancorporation
VTVT14.20-0.73
-4.89%
vTv Therapeutics